FDA Inspection 1036268 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on Nov 16, 2017 in Royal Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Royal Palm Beach, FL (United States)